Multiple doses of tetanus toxoid are used by many plasma centers in the United States for the development of highly immune persons for the production of human anti-tetanus immune globulin ( tetanus immune globulin ( TIG ), HyperTet ( c ) ), which has replaced horse serum-type tetanus antitoxin in most of the developed world.